数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Zachary S. Wochok Director 77 9.08万美元 未持股 2020-09-16
Robert A. Woods Director, Chairman of the board 77 11.93万美元 未持股 2020-09-16
Yogesh Mago Director 39 8.46万美元 未持股 2020-09-16
Keith McGovern Director 55 7.50万美元 未持股 2020-09-16
Stuart Woolf Director 61 7.50万美元 未持股 2020-09-16
Kevin Helash Director, Chief Executive Officer 56 未披露 未持股 2020-09-16
Pamela G. Marrone Director 63 89.42万美元 未持股 2020-09-16

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Amit Vasavada -- Senior Vice President, Research and Development and Chief Technology Officer 65 未披露 未持股 2020-09-16
Tim Johnson -- Vice President of Field Development and Technical Services 64 未披露 未持股 2020-09-16
Kevin Helash Director, Chief Executive Officer 56 未披露 未持股 2020-09-16
Kevin Hammill Chief Commercial Officer 53 70.12万美元 未持股 2020-09-16
Keith Pitts Senior Vice President, Regulatory and Government Affairs and Chief Sustainability Officer 57 未披露 未持股 2020-09-16
James B. Boyd President and Chief Financial Officer 67 70.44万美元 未持股 2020-09-16
Linda V. Moore Executive Vice President, General Counsel, Secretary and Chief Compliance Officer 73 31.35万美元 未持股 2020-09-16

董事简历

中英对照 |  中文 |  英文
Zachary S. Wochok

Zachary S. Wochok,2011年10月以来,他担任The Wochok Group, LLC(一个管理咨询公司)的总裁和创始人。超过25年,他担任农业、生物技术和食品行业的各种执行职务,包括从2011年4月到2011年10月,他担任PGP International, Inc.(一个食品公司)的董事长;从1996年2月到2011年3月,他担任其首席执行官;他担任NURTURE, Inc.的董事长和首席执行官;他担任NURTURE, Inc.(当时是上市公司)的总裁和首席执行官;他担任Plant Genetics(当时公司完成首次公开发行(ipo),后来和Calgene, Inc合并创造美国最大的植物生物技术公司)的首席执行官。他也担任Monsanto新企业部门业务拓展经理和Weyerhaeuser Company的首席科学家。他的事业始于在the University of Alabama担任生物学教授。随后成为Yale University的国家卫生研究院资助的博士后。他获得LaSalle University的生物学学士学位、Villanova University的生物学硕士学位和the University of Connecticut的细胞生物学和植物生理学博士学位。


Zachary S. Wochok has served on our board of directors since May 2016. He served as president and founder of The Wochok Group, LLC, a management consulting firm, since October 2011. For over 25 years, Dr. Wochok has held executive positions in the agribusiness, biotechnology and food industries, including service as Chairman of PGP International, Inc., a food ingredients company, from April 2011 to October 2011 and as its chief executive officer from February 1996 to March 2011 as the Chairman and Chief Executive Officer of NURTURE, Inc., as president and chief operating officer of Calgene, Inc., which was then publicly traded, and as the chief executive officer of Plant Genetics, Inc., during which time the company completed an initial public offering and later merged with Calgene, Inc., creating the largest plant biotechnology company in the United States at the time. Dr. Wochok has served as a director and President of Grazix Animal Health, Inc. from July 2015 to July 2019; as Director of Live Leaf, Inc. from April 2017 to July 2019; on the board of Nucelis, Inc., a fermentation based specialty chemical company, from March 2012 to December 2014; as advisor to the board of directors of Cibus Global, Ltd. from January 2015 to July 2017; as agricultural technology business advisor to Alexandria Real Estate Equities, Inc. from January 2015 to February 2017; and on the Advisory Board of AgTech Accelerator from May 2016 to May 2017. He has also served as business development manager in the new ventures department at Monsanto and a lead scientist for Weyerhaeuser Company. Dr. Wochok began his career as a professor of biology at the University of Alabama, following an NIH funded post-doctoral position at Yale University. Dr. Wochok received a B.A. in Biology from LaSalle University, an M.S. in Biology from Villanova University and a Ph.D. in Cell Biology and Plant Physiology from the University of Connecticut.
Zachary S. Wochok,2011年10月以来,他担任The Wochok Group, LLC(一个管理咨询公司)的总裁和创始人。超过25年,他担任农业、生物技术和食品行业的各种执行职务,包括从2011年4月到2011年10月,他担任PGP International, Inc.(一个食品公司)的董事长;从1996年2月到2011年3月,他担任其首席执行官;他担任NURTURE, Inc.的董事长和首席执行官;他担任NURTURE, Inc.(当时是上市公司)的总裁和首席执行官;他担任Plant Genetics(当时公司完成首次公开发行(ipo),后来和Calgene, Inc合并创造美国最大的植物生物技术公司)的首席执行官。他也担任Monsanto新企业部门业务拓展经理和Weyerhaeuser Company的首席科学家。他的事业始于在the University of Alabama担任生物学教授。随后成为Yale University的国家卫生研究院资助的博士后。他获得LaSalle University的生物学学士学位、Villanova University的生物学硕士学位和the University of Connecticut的细胞生物学和植物生理学博士学位。
Zachary S. Wochok has served on our board of directors since May 2016. He served as president and founder of The Wochok Group, LLC, a management consulting firm, since October 2011. For over 25 years, Dr. Wochok has held executive positions in the agribusiness, biotechnology and food industries, including service as Chairman of PGP International, Inc., a food ingredients company, from April 2011 to October 2011 and as its chief executive officer from February 1996 to March 2011 as the Chairman and Chief Executive Officer of NURTURE, Inc., as president and chief operating officer of Calgene, Inc., which was then publicly traded, and as the chief executive officer of Plant Genetics, Inc., during which time the company completed an initial public offering and later merged with Calgene, Inc., creating the largest plant biotechnology company in the United States at the time. Dr. Wochok has served as a director and President of Grazix Animal Health, Inc. from July 2015 to July 2019; as Director of Live Leaf, Inc. from April 2017 to July 2019; on the board of Nucelis, Inc., a fermentation based specialty chemical company, from March 2012 to December 2014; as advisor to the board of directors of Cibus Global, Ltd. from January 2015 to July 2017; as agricultural technology business advisor to Alexandria Real Estate Equities, Inc. from January 2015 to February 2017; and on the Advisory Board of AgTech Accelerator from May 2016 to May 2017. He has also served as business development manager in the new ventures department at Monsanto and a lead scientist for Weyerhaeuser Company. Dr. Wochok began his career as a professor of biology at the University of Alabama, following an NIH funded post-doctoral position at Yale University. Dr. Wochok received a B.A. in Biology from LaSalle University, an M.S. in Biology from Villanova University and a Ph.D. in Cell Biology and Plant Physiology from the University of Connecticut.
Robert A. Woods

Robert A.Woods自2018年2月以来一直担任我们的董事会成员和董事会主席。他在农业企业和农产品方面有着五十多年的经验。Woods先生曾担任Target Growth Inc.(一家生物技术公司,专注于提高农艺作物产量)的董事长兼首席执行官。此前,他曾担任Athena Biotechnologies,Inc.的首席执行官、Syngenta Corporation US的主席、Zeneca AG Products的集团总裁、Garst Seed Company的首席执行官。他最近从The Gowan Company的董事会退休,曾担任多种职务14年。Woods先生于2019年4月加入以色列农业技术发现公司AG Plenus的董事会。从2007年到2016年,Woods先生是Vertellus Specialties Inc.的顾问兼董事会成员。自2018年2月以来,伍兹先生一直担任Ospraie Management LLC的顾问,该公司是我们股东之一的关联公司。Woods先生拥有马尼托巴省温尼伯的马尼托巴大学(University of Manitoba)农业和园艺学士学位。


Robert A. Woods has served on our board of directors and as Chairman of the board of directors since February 2018. He has more than fifty years of experience in agribusiness and agriculture products. Mr. Woods formerly served as the Chairman and Chief Executive Officer of Targeted Growth Inc., a biotechnology firm focused on improving yield in agronomic crops. Prior to that, he served as Chief Executive Officer of Athena Biotechnologies, Inc., Chairman of Syngenta Corporation US, Group President for Zeneca Ag Products and CEO of Garst Seed Company. He has recently retired from the board of the Gowan Company having served in various capacities for 14 years. In April of 2019 Mr. Woods joined the board of Ag Plenus, an Israeli company in Agricultural technology discovery. From 2007 to 2016 Mr. Woods was a consultant and board member with Vertellus Specialties Inc. Since February 2018 Mr. Woods has served as a consultant with Ospraie Management LLC, an affiliate of one of our stockholders. Mr. Woods has a Bachelors’ degree in Agriculture and Horticulture from the University of Manitoba in Winnipeg, Manitoba.
Robert A.Woods自2018年2月以来一直担任我们的董事会成员和董事会主席。他在农业企业和农产品方面有着五十多年的经验。Woods先生曾担任Target Growth Inc.(一家生物技术公司,专注于提高农艺作物产量)的董事长兼首席执行官。此前,他曾担任Athena Biotechnologies,Inc.的首席执行官、Syngenta Corporation US的主席、Zeneca AG Products的集团总裁、Garst Seed Company的首席执行官。他最近从The Gowan Company的董事会退休,曾担任多种职务14年。Woods先生于2019年4月加入以色列农业技术发现公司AG Plenus的董事会。从2007年到2016年,Woods先生是Vertellus Specialties Inc.的顾问兼董事会成员。自2018年2月以来,伍兹先生一直担任Ospraie Management LLC的顾问,该公司是我们股东之一的关联公司。Woods先生拥有马尼托巴省温尼伯的马尼托巴大学(University of Manitoba)农业和园艺学士学位。
Robert A. Woods has served on our board of directors and as Chairman of the board of directors since February 2018. He has more than fifty years of experience in agribusiness and agriculture products. Mr. Woods formerly served as the Chairman and Chief Executive Officer of Targeted Growth Inc., a biotechnology firm focused on improving yield in agronomic crops. Prior to that, he served as Chief Executive Officer of Athena Biotechnologies, Inc., Chairman of Syngenta Corporation US, Group President for Zeneca Ag Products and CEO of Garst Seed Company. He has recently retired from the board of the Gowan Company having served in various capacities for 14 years. In April of 2019 Mr. Woods joined the board of Ag Plenus, an Israeli company in Agricultural technology discovery. From 2007 to 2016 Mr. Woods was a consultant and board member with Vertellus Specialties Inc. Since February 2018 Mr. Woods has served as a consultant with Ospraie Management LLC, an affiliate of one of our stockholders. Mr. Woods has a Bachelors’ degree in Agriculture and Horticulture from the University of Manitoba in Winnipeg, Manitoba.
Yogesh Mago

Yogesh Mago自2018年2月起担任我们的董事会成员。他一直担任Ospraie AG Science LLC(我们的股东之一)的高级顾问(2016年10月以来),并拥有超过15年的投资经验,涉及全球多种行业,包括农业、旅游、消费、运输、工业和房地产。Mago先生是Operation Water Inc.的总裁兼联合创始人,该公司是一家非营利组织,旨在通过开发可扩展的基础设施项目,为贫困国家提供可持续的清洁用水。此外,他还是女童崛起组织(Girl Rising)的顾问委员会成员,该组织是全球女童教育和赋权社会行动运动背后的非营利组织。Mago先生拥有纽约大学(New York University)金融与国际商务学士学位。


Yogesh Mago has served as Bioceres Crop Solutions Corp's non-executive director since July 12 2022. He has been a senior advisor for Ospraie Ag Science LLC, following the closing of the Pro Farm Merger one of Bioceres Crop Solutions Corp's shareholders, since October 2016 and has over 15 years of experience in investing across a variety of industries globally, including agriculture, travel, consumer, transportation, industrials and real estate. Mr. Mago is the president and co-founder of Operation Water Inc., a nonprofit organization that aims to deliver sustainable access to clean water in impoverished countries through the development of scalable infrastructure projects. In addition, he is on the Advisory Board of Girl Rising, the nonprofit organization behind the worldwide social action campaign for girls' education and empowerment. Mr. Mago has a Bachelor's degree in Finance and International Business from New York University.
Yogesh Mago自2018年2月起担任我们的董事会成员。他一直担任Ospraie AG Science LLC(我们的股东之一)的高级顾问(2016年10月以来),并拥有超过15年的投资经验,涉及全球多种行业,包括农业、旅游、消费、运输、工业和房地产。Mago先生是Operation Water Inc.的总裁兼联合创始人,该公司是一家非营利组织,旨在通过开发可扩展的基础设施项目,为贫困国家提供可持续的清洁用水。此外,他还是女童崛起组织(Girl Rising)的顾问委员会成员,该组织是全球女童教育和赋权社会行动运动背后的非营利组织。Mago先生拥有纽约大学(New York University)金融与国际商务学士学位。
Yogesh Mago has served as Bioceres Crop Solutions Corp's non-executive director since July 12 2022. He has been a senior advisor for Ospraie Ag Science LLC, following the closing of the Pro Farm Merger one of Bioceres Crop Solutions Corp's shareholders, since October 2016 and has over 15 years of experience in investing across a variety of industries globally, including agriculture, travel, consumer, transportation, industrials and real estate. Mr. Mago is the president and co-founder of Operation Water Inc., a nonprofit organization that aims to deliver sustainable access to clean water in impoverished countries through the development of scalable infrastructure projects. In addition, he is on the Advisory Board of Girl Rising, the nonprofit organization behind the worldwide social action campaign for girls' education and empowerment. Mr. Mago has a Bachelor's degree in Finance and International Business from New York University.
Keith McGovern

Keith McGovern在农业行业拥有超过30年的经验,专门从事领先的商业马铃薯种植和马铃薯加工业务。他是R.D.Offutt Farms(R.D.Offutt Company的一个部门,美国最大的农业和食品加工企业之一)的总裁。McGovern先生于1988年8月加入R.D.Offutt Company。McGovern先生任职于Lamb-Weston/RDO Frozen的管理委员会,这是一家合资企业冷冻土豆产品加工厂。他也任职于Alliance for Potato Research and Education公司的董事会、Columbia River Technologies公司(乳清处理器,与Tillamook公司和恒天然公司合作)的管理委员会,以及Simplot RDO公司(位于华盛顿帕斯科的冷冻蔬菜工厂)的管理委员会。McGovern先生毕业于Embry Riddle Aeronautical University,获得航空科学学位,目前仍是一名活跃的飞行员。


Keith McGovern has over 30 years of experience in the agriculture industry, specializing in leading commercial potato farming and potato processing operations. He is President of R.D. Offutt Farms, a division of R.D. Offutt Company, one of the largest farming and food processing concerns in the United States. Mr. McGovern joined R.D. Offutt Company in August 1988. Mr. McGovern serves on the Management Committee of Lamb-Weston/RDO Frozen, a joint venture frozen potato product processing plant. He also serves on the Board of Alliance for Potato Research and Education, on the Management Committee for Columbia River Technologies, a whey processor in partnership with Tillamook and Fonterra, and the Management Committee for Simplot RDO, a frozen vegetable plant in Pasco, Washington. Mr. McGovern is a graduate of Embry Riddle Aeronautical University with a degree in Aeronautical Science, and is still an active pilot.
Keith McGovern在农业行业拥有超过30年的经验,专门从事领先的商业马铃薯种植和马铃薯加工业务。他是R.D.Offutt Farms(R.D.Offutt Company的一个部门,美国最大的农业和食品加工企业之一)的总裁。McGovern先生于1988年8月加入R.D.Offutt Company。McGovern先生任职于Lamb-Weston/RDO Frozen的管理委员会,这是一家合资企业冷冻土豆产品加工厂。他也任职于Alliance for Potato Research and Education公司的董事会、Columbia River Technologies公司(乳清处理器,与Tillamook公司和恒天然公司合作)的管理委员会,以及Simplot RDO公司(位于华盛顿帕斯科的冷冻蔬菜工厂)的管理委员会。McGovern先生毕业于Embry Riddle Aeronautical University,获得航空科学学位,目前仍是一名活跃的飞行员。
Keith McGovern has over 30 years of experience in the agriculture industry, specializing in leading commercial potato farming and potato processing operations. He is President of R.D. Offutt Farms, a division of R.D. Offutt Company, one of the largest farming and food processing concerns in the United States. Mr. McGovern joined R.D. Offutt Company in August 1988. Mr. McGovern serves on the Management Committee of Lamb-Weston/RDO Frozen, a joint venture frozen potato product processing plant. He also serves on the Board of Alliance for Potato Research and Education, on the Management Committee for Columbia River Technologies, a whey processor in partnership with Tillamook and Fonterra, and the Management Committee for Simplot RDO, a frozen vegetable plant in Pasco, Washington. Mr. McGovern is a graduate of Embry Riddle Aeronautical University with a degree in Aeronautical Science, and is still an active pilot.
Stuart Woolf

Stuart Woolf,2002年起,担任Woolf Farming&Processing的总裁、首席执行官。他还担任Harris Woolf California Almonds(生杏仁的加工商和处理商)和Los Gatos番茄制品公司(为工业用户制造散装番茄酱)的管理合伙人。Woolf曾担任California League of Food Processor、California Almond Board和University of California农业和自然资源委员会主席。Woolf先生目前任职于Ruiz Food Products and Western Growers Association的董事会。Woolf先生在加州大学伯克利分校(University of California at Berkeley)获得文科学士学位,并在波士顿学院(Boston College)获得工商管理硕士学位。


Stuart Woolf has served as President and CEO of Woolf Farming & Processing since 2002. He also serves as the Managing Partner for Harris Woolf California Almonds, a processor and handler of raw almonds, and Los Gatos Tomato Products, which manufactures bulk tomato paste for industrial users. Mr. Woolf has served as Chairman of the California League of Food Processors, the Almond Board of California, and of the University of California President’s Commission of Agriculture and Natural Resources. Mr. Woolf currently serves on the board of Ruiz Food Products and Western Growers Association. Mr. Woolf received a bachelor’s degree in Liberal Arts from the University of California at Berkeley and an MBA at Boston College.
Stuart Woolf,2002年起,担任Woolf Farming&Processing的总裁、首席执行官。他还担任Harris Woolf California Almonds(生杏仁的加工商和处理商)和Los Gatos番茄制品公司(为工业用户制造散装番茄酱)的管理合伙人。Woolf曾担任California League of Food Processor、California Almond Board和University of California农业和自然资源委员会主席。Woolf先生目前任职于Ruiz Food Products and Western Growers Association的董事会。Woolf先生在加州大学伯克利分校(University of California at Berkeley)获得文科学士学位,并在波士顿学院(Boston College)获得工商管理硕士学位。
Stuart Woolf has served as President and CEO of Woolf Farming & Processing since 2002. He also serves as the Managing Partner for Harris Woolf California Almonds, a processor and handler of raw almonds, and Los Gatos Tomato Products, which manufactures bulk tomato paste for industrial users. Mr. Woolf has served as Chairman of the California League of Food Processors, the Almond Board of California, and of the University of California President’s Commission of Agriculture and Natural Resources. Mr. Woolf currently serves on the board of Ruiz Food Products and Western Growers Association. Mr. Woolf received a bachelor’s degree in Liberal Arts from the University of California at Berkeley and an MBA at Boston College.
Kevin Helash

Kevin Helash于2020年8月加入我们,担任首席执行官兼董事。在加入公司之前,他于2017年11月至2020年7月担任Agrinos的首席执行官,Agrinos是一家生物作物输入提供商,在加利福尼亚州戴维斯设有美国办事处。在加入Agrinos之前,Helash先生于1991年至2017年受聘于Agrium Now NutrienLtd.(全球最大的农产品分销商之一),担任多个职位,包括领导全球销售,营销,物流和供应链战略的高级管理职位,最后担任Agrium Retail Canada Vice President。Helash先生持有曼尼托巴大学(University of Manitoba)农业理学学士学位。


Kevin Helash joined us as Chief Executive Officer and director in August 2020. Prior to joining the Company, he served as the CEO of Agrinos, a biological crop input provider with U.S. offices in Davis, California, from November 2017 to July 2020. Prior to joining Agrinos, from 1991 to 2017 Mr. Helash was employed at Agrium now Nutrien Ltd., one of the world’s largest agricultural product distributors, in various positions, including senior management roles leading global sales, marketing, logistics and supply chain strategies and last serving as Vice President, Agrium Retail Canada. Mr. Helash holds a Bachelor of Science degree in agriculture from the University of Manitoba.
Kevin Helash于2020年8月加入我们,担任首席执行官兼董事。在加入公司之前,他于2017年11月至2020年7月担任Agrinos的首席执行官,Agrinos是一家生物作物输入提供商,在加利福尼亚州戴维斯设有美国办事处。在加入Agrinos之前,Helash先生于1991年至2017年受聘于Agrium Now NutrienLtd.(全球最大的农产品分销商之一),担任多个职位,包括领导全球销售,营销,物流和供应链战略的高级管理职位,最后担任Agrium Retail Canada Vice President。Helash先生持有曼尼托巴大学(University of Manitoba)农业理学学士学位。
Kevin Helash joined us as Chief Executive Officer and director in August 2020. Prior to joining the Company, he served as the CEO of Agrinos, a biological crop input provider with U.S. offices in Davis, California, from November 2017 to July 2020. Prior to joining Agrinos, from 1991 to 2017 Mr. Helash was employed at Agrium now Nutrien Ltd., one of the world’s largest agricultural product distributors, in various positions, including senior management roles leading global sales, marketing, logistics and supply chain strategies and last serving as Vice President, Agrium Retail Canada. Mr. Helash holds a Bachelor of Science degree in agriculture from the University of Manitoba.
Pamela G. Marrone

Pamela G. Marrone,自2021年7月2日起担任180 Life Sciences Corp. Company的董事。Marrone博士目前是入侵物种公司的联合创始人和执行主席,为控制水、林业和农业中困难的入侵物种提供生物解决方案。从2006年4月到2020年8月退休,她是Marrone Bio Innovations, Inc.(NASDAQ:MBII)的创始人兼首席执行官,这是一家生产害虫管理和植物健康产品的天然产品公司,然后在董事会任职,直到2022年7月出售给Bioceres Crop Solutions。2022年7月,她被选为Elicit Plant的董事会主席,这是一家法国风险资本支持的公司,开发和销售植物天然产品,以减少作物压力。2021年7月,她被任命为Arizona State University's Swette Center for Sustainable Food Systems的高级研究员。她目前还担任Stem Express LLC的董事会成员。在创立Marrone Bio之前,Marrone博士于1995年创立AgraQuest, Inc.(被Bayer收购),在那里她担任董事会成员、总裁兼首席执行官直到2004年5月,从那时起担任董事会成员、总裁或主席直到2006年3月,她一直在董事会任职直到2007年3月。在那里,她领导的团队发现了几种生物基害虫管理产品并将其商业化。1990年至1995年,她担任Entotech, Inc.(丹麦Novo Nordisk a /S的生物农药子公司,被Abbott Laboratories)的创始总裁和业务部门主管;1983年至1990年,她在Monsanto Company担任多个职位,在那里她领导昆虫生物学集团,参与转基因作物、天然产品和微生物农药的开创性项目。Marrone博士是二十多份受邀出版物的作者,400多项专利的发明人,是一名受欢迎的演讲者,并在众多专业和学术组织的董事会和咨询委员会任职。2016年,Marrone博士当选为Cornell University董事会成员,并于2020年7月完成了她的四年任期。2013年,Marrone博士被《Sacramento Business Journal》评为Sacramento地区“年度执行官”,被Sacramento地区技术联盟评为“年度清洁技术创新者”,并于2014年被Agrow评为具有战略眼光的最佳经理。2019年1月,她被生态农业协会授予“Sustie”奖,以表彰她在可持续农业领域长达数十年的领导。2020年3月,她被《Sacramento Business Journal》授予最受尊敬的首席执行官杰出职业奖。2022年,她是第一位获得美国化学学会颁发的Kathryn C. Hach创业成功奖的女性。Marrone博士获得Cornell University昆虫学学士学位和North Carolina State University昆虫学博士学位。


Pamela G. Marrone,has been a director of 180 Life Sciences Corp. Company since July 2, 2021. Dr. Marrone is currently co-founder and Executive Chair of the Invasive Species Corporation, bringing biological solutions to control difficult invasive species in water, forestry and agriculture. She was founder and was Chief Executive Officer of Marrone Bio Innovations, Inc. (NASDAQ:MBII), a natural products company producing pest management and plant health products, from April 2006 until her retirement in August 2020, and then served on the Board of Directors until its sale to Bioceres Crop Solutions in July 2022. In July 2022, she was elected Chair of the Board of Directors of Elicit Plant, a French venture capital-backed company developing and selling plant natural products to reduce crop stress. In July 2021, she was appointed as senior fellow of Arizona State University's Swette Center for Sustainable Food Systems. She also currently serves on the board of Stem Express LLC. Prior to founding Marrone Bio, in 1995 Dr. Marrone founded AgraQuest, Inc. (acquired by Bayer), where she served as board member, president and chief executive officer until May 2004 and as board member, president or chair from such time until March 2006 and she remained on the board until March 2007. While there, she led teams that discovered and commercialized several bio-based pest management products. She served as founding president and business unit head for Entotech, Inc., a biopesticide subsidiary of Denmark-based Novo Nordisk A/S (acquired by Abbott Laboratories), from 1990 to 1995, and held various positions at the Monsanto Company from 1983 until 1990, where she led the Insect Biology Group, which was involved in pioneering projects in transgenic crops, natural products and microbial pesticides. Dr. Marrone is an author of over twenty invited publications, an inventor on more than 400 patents and is in demand as a speaker and has served on the boards and advisory councils of numerous professional and academic organizations. In 2016, Dr. Marrone was elected to the Cornell University Board of Trustees and completed her four-year term in July 2020. In 2013, Dr. Marrone was named the Sacramento region's "Executive of the Year" by the Sacramento Business Journal and "Cleantech Innovator of the Year" by the Sacramento Area Regional Technology Alliance and Best Manager with Strategic Vision by Agrow in 2014. In January 2019, she was awarded the "Sustie" award by the Ecological Farming Association for her decades-long leadership in sustainable agriculture. In March 2020, she was awarded the Most Admired CEO, Distinguished Career Award by the Sacramento Business Journal. In 2022, she was the first woman to receive the Kathryn C. Hach Award for Entrepreneurial Success from the American Chemical Society. Dr. Marrone earned a B.S. in Entomology from Cornell University and a Ph.D. in Entomology from North Carolina State University.
Pamela G. Marrone,自2021年7月2日起担任180 Life Sciences Corp. Company的董事。Marrone博士目前是入侵物种公司的联合创始人和执行主席,为控制水、林业和农业中困难的入侵物种提供生物解决方案。从2006年4月到2020年8月退休,她是Marrone Bio Innovations, Inc.(NASDAQ:MBII)的创始人兼首席执行官,这是一家生产害虫管理和植物健康产品的天然产品公司,然后在董事会任职,直到2022年7月出售给Bioceres Crop Solutions。2022年7月,她被选为Elicit Plant的董事会主席,这是一家法国风险资本支持的公司,开发和销售植物天然产品,以减少作物压力。2021年7月,她被任命为Arizona State University's Swette Center for Sustainable Food Systems的高级研究员。她目前还担任Stem Express LLC的董事会成员。在创立Marrone Bio之前,Marrone博士于1995年创立AgraQuest, Inc.(被Bayer收购),在那里她担任董事会成员、总裁兼首席执行官直到2004年5月,从那时起担任董事会成员、总裁或主席直到2006年3月,她一直在董事会任职直到2007年3月。在那里,她领导的团队发现了几种生物基害虫管理产品并将其商业化。1990年至1995年,她担任Entotech, Inc.(丹麦Novo Nordisk a /S的生物农药子公司,被Abbott Laboratories)的创始总裁和业务部门主管;1983年至1990年,她在Monsanto Company担任多个职位,在那里她领导昆虫生物学集团,参与转基因作物、天然产品和微生物农药的开创性项目。Marrone博士是二十多份受邀出版物的作者,400多项专利的发明人,是一名受欢迎的演讲者,并在众多专业和学术组织的董事会和咨询委员会任职。2016年,Marrone博士当选为Cornell University董事会成员,并于2020年7月完成了她的四年任期。2013年,Marrone博士被《Sacramento Business Journal》评为Sacramento地区“年度执行官”,被Sacramento地区技术联盟评为“年度清洁技术创新者”,并于2014年被Agrow评为具有战略眼光的最佳经理。2019年1月,她被生态农业协会授予“Sustie”奖,以表彰她在可持续农业领域长达数十年的领导。2020年3月,她被《Sacramento Business Journal》授予最受尊敬的首席执行官杰出职业奖。2022年,她是第一位获得美国化学学会颁发的Kathryn C. Hach创业成功奖的女性。Marrone博士获得Cornell University昆虫学学士学位和North Carolina State University昆虫学博士学位。
Pamela G. Marrone,has been a director of 180 Life Sciences Corp. Company since July 2, 2021. Dr. Marrone is currently co-founder and Executive Chair of the Invasive Species Corporation, bringing biological solutions to control difficult invasive species in water, forestry and agriculture. She was founder and was Chief Executive Officer of Marrone Bio Innovations, Inc. (NASDAQ:MBII), a natural products company producing pest management and plant health products, from April 2006 until her retirement in August 2020, and then served on the Board of Directors until its sale to Bioceres Crop Solutions in July 2022. In July 2022, she was elected Chair of the Board of Directors of Elicit Plant, a French venture capital-backed company developing and selling plant natural products to reduce crop stress. In July 2021, she was appointed as senior fellow of Arizona State University's Swette Center for Sustainable Food Systems. She also currently serves on the board of Stem Express LLC. Prior to founding Marrone Bio, in 1995 Dr. Marrone founded AgraQuest, Inc. (acquired by Bayer), where she served as board member, president and chief executive officer until May 2004 and as board member, president or chair from such time until March 2006 and she remained on the board until March 2007. While there, she led teams that discovered and commercialized several bio-based pest management products. She served as founding president and business unit head for Entotech, Inc., a biopesticide subsidiary of Denmark-based Novo Nordisk A/S (acquired by Abbott Laboratories), from 1990 to 1995, and held various positions at the Monsanto Company from 1983 until 1990, where she led the Insect Biology Group, which was involved in pioneering projects in transgenic crops, natural products and microbial pesticides. Dr. Marrone is an author of over twenty invited publications, an inventor on more than 400 patents and is in demand as a speaker and has served on the boards and advisory councils of numerous professional and academic organizations. In 2016, Dr. Marrone was elected to the Cornell University Board of Trustees and completed her four-year term in July 2020. In 2013, Dr. Marrone was named the Sacramento region's "Executive of the Year" by the Sacramento Business Journal and "Cleantech Innovator of the Year" by the Sacramento Area Regional Technology Alliance and Best Manager with Strategic Vision by Agrow in 2014. In January 2019, she was awarded the "Sustie" award by the Ecological Farming Association for her decades-long leadership in sustainable agriculture. In March 2020, she was awarded the Most Admired CEO, Distinguished Career Award by the Sacramento Business Journal. In 2022, she was the first woman to receive the Kathryn C. Hach Award for Entrepreneurial Success from the American Chemical Society. Dr. Marrone earned a B.S. in Entomology from Cornell University and a Ph.D. in Entomology from North Carolina State University.

高管简历

中英对照 |  中文 |  英文
Amit Vasavada

Amit Vasavada, Vasavada 于2014年3月被任命为我们的研发副总裁。从2009年到2014年,Vasavada 担任General Atomics的项目经理。2006年以来,Vasavada 曾任职于Vaxiion Therapeutics的科学咨询委员会。2008年至2014年,Vasavada 曾担任NewCos(应用微生物学和生物技术开发公司)的科学顾问。Vasavada 持有Gujarat University的微生物学学士学位、University of Louisiana的微生物学硕士学位,以及加州大学戴维斯分校(University of California, Davis)的应用微生物学博士学位。


Amit Vasavada was appointed as Vice President of Research and Development in March 2014 and Senior Vice President and Chief Technology Officer effective March 16 2017. From 2009 to 2014 Dr. Vasavada served as a program manager at General Atomics. Since 2006 Dr. Vasavada has served on the scientific advisory board of Vaxiion Therapeutics and from 2008 to 2014 served as scientific advisor to NewCos, an applied microbiology and algae-based technology development company. Dr. Vasavada earned a B.S. in microbiology from Gujarat University, an M.S. in microbiology from University of Louisiana and a Ph.D. in applied microbiology from University of California, Davis.
Amit Vasavada, Vasavada 于2014年3月被任命为我们的研发副总裁。从2009年到2014年,Vasavada 担任General Atomics的项目经理。2006年以来,Vasavada 曾任职于Vaxiion Therapeutics的科学咨询委员会。2008年至2014年,Vasavada 曾担任NewCos(应用微生物学和生物技术开发公司)的科学顾问。Vasavada 持有Gujarat University的微生物学学士学位、University of Louisiana的微生物学硕士学位,以及加州大学戴维斯分校(University of California, Davis)的应用微生物学博士学位。
Amit Vasavada was appointed as Vice President of Research and Development in March 2014 and Senior Vice President and Chief Technology Officer effective March 16 2017. From 2009 to 2014 Dr. Vasavada served as a program manager at General Atomics. Since 2006 Dr. Vasavada has served on the scientific advisory board of Vaxiion Therapeutics and from 2008 to 2014 served as scientific advisor to NewCos, an applied microbiology and algae-based technology development company. Dr. Vasavada earned a B.S. in microbiology from Gujarat University, an M.S. in microbiology from University of Louisiana and a Ph.D. in applied microbiology from University of California, Davis.
Tim Johnson

Tim Johnson,于2015年8月被任命为现场开发和技术服务副总裁。Johnson此前曾担任我们的全球产品开发主管(2011年6月至2015年8月)、产品开发经理(2009年5月至2011年6月)和美国东部产品开发经理(2009年11月至2009年5月)。2002年6月至2008年11月,Johnson曾担任Plato Industries, Ltd的商业开发经理。Johnson持有Iowa State University的昆虫和害虫管理的学士学位、Iowa State University的昆虫学硕士学位、Purdue University的昆虫学博士学位。


Tim Johnson was appointed as Vice President of Field Development and Technical Services in August 2015. Dr. Johnson previously served as our Global Product Development Director, Product Development Manager and Eastern U.S. Product Development Manager from June 2011 to August 2015 May 2009 to June 2011 and November 2008 to May 2009 respectively. From June 2002 to November 2008 Dr. Johnson served as manager of commercial development for Plato Industries, Ltd. Dr. Johnson earned a B.S. in Entomology and Pest Management from Iowa State University, an M.S. in Entomology from Iowa State University and a Ph.D. in Entomology from Purdue University.
Tim Johnson,于2015年8月被任命为现场开发和技术服务副总裁。Johnson此前曾担任我们的全球产品开发主管(2011年6月至2015年8月)、产品开发经理(2009年5月至2011年6月)和美国东部产品开发经理(2009年11月至2009年5月)。2002年6月至2008年11月,Johnson曾担任Plato Industries, Ltd的商业开发经理。Johnson持有Iowa State University的昆虫和害虫管理的学士学位、Iowa State University的昆虫学硕士学位、Purdue University的昆虫学博士学位。
Tim Johnson was appointed as Vice President of Field Development and Technical Services in August 2015. Dr. Johnson previously served as our Global Product Development Director, Product Development Manager and Eastern U.S. Product Development Manager from June 2011 to August 2015 May 2009 to June 2011 and November 2008 to May 2009 respectively. From June 2002 to November 2008 Dr. Johnson served as manager of commercial development for Plato Industries, Ltd. Dr. Johnson earned a B.S. in Entomology and Pest Management from Iowa State University, an M.S. in Entomology from Iowa State University and a Ph.D. in Entomology from Purdue University.
Kevin Helash

Kevin Helash于2020年8月加入我们,担任首席执行官兼董事。在加入公司之前,他于2017年11月至2020年7月担任Agrinos的首席执行官,Agrinos是一家生物作物输入提供商,在加利福尼亚州戴维斯设有美国办事处。在加入Agrinos之前,Helash先生于1991年至2017年受聘于Agrium Now NutrienLtd.(全球最大的农产品分销商之一),担任多个职位,包括领导全球销售,营销,物流和供应链战略的高级管理职位,最后担任Agrium Retail Canada Vice President。Helash先生持有曼尼托巴大学(University of Manitoba)农业理学学士学位。


Kevin Helash joined us as Chief Executive Officer and director in August 2020. Prior to joining the Company, he served as the CEO of Agrinos, a biological crop input provider with U.S. offices in Davis, California, from November 2017 to July 2020. Prior to joining Agrinos, from 1991 to 2017 Mr. Helash was employed at Agrium now Nutrien Ltd., one of the world’s largest agricultural product distributors, in various positions, including senior management roles leading global sales, marketing, logistics and supply chain strategies and last serving as Vice President, Agrium Retail Canada. Mr. Helash holds a Bachelor of Science degree in agriculture from the University of Manitoba.
Kevin Helash于2020年8月加入我们,担任首席执行官兼董事。在加入公司之前,他于2017年11月至2020年7月担任Agrinos的首席执行官,Agrinos是一家生物作物输入提供商,在加利福尼亚州戴维斯设有美国办事处。在加入Agrinos之前,Helash先生于1991年至2017年受聘于Agrium Now NutrienLtd.(全球最大的农产品分销商之一),担任多个职位,包括领导全球销售,营销,物流和供应链战略的高级管理职位,最后担任Agrium Retail Canada Vice President。Helash先生持有曼尼托巴大学(University of Manitoba)农业理学学士学位。
Kevin Helash joined us as Chief Executive Officer and director in August 2020. Prior to joining the Company, he served as the CEO of Agrinos, a biological crop input provider with U.S. offices in Davis, California, from November 2017 to July 2020. Prior to joining Agrinos, from 1991 to 2017 Mr. Helash was employed at Agrium now Nutrien Ltd., one of the world’s largest agricultural product distributors, in various positions, including senior management roles leading global sales, marketing, logistics and supply chain strategies and last serving as Vice President, Agrium Retail Canada. Mr. Helash holds a Bachelor of Science degree in agriculture from the University of Manitoba.
Kevin Hammill

Kevin Hammill被任命为首席商务官,自2019年5月起生效。Hammill先生此前于2016年1月至2018年4月担任作物营养公司Pivot Bio的首席运营官。加入Pivot Bio之前,Hammill从2004年到2016年1月在Valent USA(Sumitomo Chemical分部)担任多个职位,包括农业业务运营和战略Vice President以及美国营销高级主管。除了这些职位外,Hammill先生还于2015年1月至2016年1月担任Valent USA董事会成员。Hammill从1992年到2004年在BASF(一家主要化学公司)和American Cynamid(2000年被BASF收购)担任多个职位。Hammill先生在加拿大安大略省盖尔夫大学(University of Guelph)获得农业理学学士学位和农业商业硕士学位。


Kevin Hammill was appointed as Chief Commercial Officer effective May 2019. Mr. Hammill previously served as chief operating officer of Pivot Bio, a crop nutrition company, from January 2016 to April 2018. Prior to Pivot Bio, from 2004 to January 2016 Mr. Hammill served in various roles at Valent USA a division of Sumitomo Chemical, including as vice president of Agriculture Business Operations and Strategy and as the senior director for U.S. Marketing. In addition to these positions, Mr. Hammill served as a member on the board of directors of Valent USA from January 2015 to January 2016. From 1992 to 2004 Mr. Hammill held multiple positions at BASF, a major chemical company, and American Cynamid (acquired by BASF in 2000). Mr. Hammill earned his Bachelor of Science degree in Agriculture and a Master’s degree in Agriculture Business from the University of Guelph in Ontario, Canada.
Kevin Hammill被任命为首席商务官,自2019年5月起生效。Hammill先生此前于2016年1月至2018年4月担任作物营养公司Pivot Bio的首席运营官。加入Pivot Bio之前,Hammill从2004年到2016年1月在Valent USA(Sumitomo Chemical分部)担任多个职位,包括农业业务运营和战略Vice President以及美国营销高级主管。除了这些职位外,Hammill先生还于2015年1月至2016年1月担任Valent USA董事会成员。Hammill从1992年到2004年在BASF(一家主要化学公司)和American Cynamid(2000年被BASF收购)担任多个职位。Hammill先生在加拿大安大略省盖尔夫大学(University of Guelph)获得农业理学学士学位和农业商业硕士学位。
Kevin Hammill was appointed as Chief Commercial Officer effective May 2019. Mr. Hammill previously served as chief operating officer of Pivot Bio, a crop nutrition company, from January 2016 to April 2018. Prior to Pivot Bio, from 2004 to January 2016 Mr. Hammill served in various roles at Valent USA a division of Sumitomo Chemical, including as vice president of Agriculture Business Operations and Strategy and as the senior director for U.S. Marketing. In addition to these positions, Mr. Hammill served as a member on the board of directors of Valent USA from January 2015 to January 2016. From 1992 to 2004 Mr. Hammill held multiple positions at BASF, a major chemical company, and American Cynamid (acquired by BASF in 2000). Mr. Hammill earned his Bachelor of Science degree in Agriculture and a Master’s degree in Agriculture Business from the University of Guelph in Ontario, Canada.
Keith Pitts

Keith Pitts, 他自2008年担任副总裁,负责政务管理。此前,2001年1月至2007年6月,他担任Pew Initiative on Food and Biotechnology(一家总部设在华盛顿特区的无党派的政策研究组织)的公共政策董事。从1986至2001年,他在美国农业部(U.S. Department of Agriculture)和众议院农业委员会(House Committee on Agriculture)担任高级立法,行政,管理和公共政策相关职位。他在University of North Carolina获得了化学学士学位。


Keith Pitts has served as our Vice President of Regulatory and Government Affairs since July 2008. Previously, from January 2001 to June 2007 Mr. Pitts served as Director of Public Policy at the Pew Initiative on Food and Biotechnology, a non-partisan research and policy organization based in Washington, D.C. From 1986 to 2001 Mr. Pitts worked in senior legislative, administrative, regulatory and public policy roles in both the U.S. Department of Agriculture and the House Committee on Agriculture. Mr. Pitts earned a B.A. in Chemistry from the University of North Carolina.
Keith Pitts, 他自2008年担任副总裁,负责政务管理。此前,2001年1月至2007年6月,他担任Pew Initiative on Food and Biotechnology(一家总部设在华盛顿特区的无党派的政策研究组织)的公共政策董事。从1986至2001年,他在美国农业部(U.S. Department of Agriculture)和众议院农业委员会(House Committee on Agriculture)担任高级立法,行政,管理和公共政策相关职位。他在University of North Carolina获得了化学学士学位。
Keith Pitts has served as our Vice President of Regulatory and Government Affairs since July 2008. Previously, from January 2001 to June 2007 Mr. Pitts served as Director of Public Policy at the Pew Initiative on Food and Biotechnology, a non-partisan research and policy organization based in Washington, D.C. From 1986 to 2001 Mr. Pitts worked in senior legislative, administrative, regulatory and public policy roles in both the U.S. Department of Agriculture and the House Committee on Agriculture. Mr. Pitts earned a B.A. in Chemistry from the University of North Carolina.
James B. Boyd

James B. Boyd,他自2014年2月担任公司副总裁兼首席财务官;自2014年3月,担任公司助理秘书长。从2012年9月至2013年9月,他担任Quantenna Communications的首席财务官。从2010年12月2012年,他担任Link-A-Media Devices的首席财务官。2007年6月至2010年11月,他担任Silicon Storage Technology的首席财务官兼高级副总裁。从2000年7月至2007年6月,他担任ESS Technology的首席财务官兼高级副总裁。他在University of Wisconsin获得了金融学MBA学位,并在Golden Gate University获得了法学博士学位。


James B. Boyd was appointed as Chief Financial Officer effective February 2014 and President effective August 2017. Mr. Boyd previously served as chief financial officer of Quantenna Communications and Link-A-Media Devices, both venture capital backed companies, from 2012 to 2013 and from 2010 to 2012 respectively. From 2007 to 2010 he served as chief financial officer and senior vice president of Silicon Storage Technology and from 2000 to 2007 Mr. Boyd served as chief financial officer and senior vice president of ESS Technology, both Nasdaq listed companies. Mr. Boyd earned a B.A. and an M.B.A. in Finance from the University of Wisconsin and a J.D. from Golden Gate University School of Law.
James B. Boyd,他自2014年2月担任公司副总裁兼首席财务官;自2014年3月,担任公司助理秘书长。从2012年9月至2013年9月,他担任Quantenna Communications的首席财务官。从2010年12月2012年,他担任Link-A-Media Devices的首席财务官。2007年6月至2010年11月,他担任Silicon Storage Technology的首席财务官兼高级副总裁。从2000年7月至2007年6月,他担任ESS Technology的首席财务官兼高级副总裁。他在University of Wisconsin获得了金融学MBA学位,并在Golden Gate University获得了法学博士学位。
James B. Boyd was appointed as Chief Financial Officer effective February 2014 and President effective August 2017. Mr. Boyd previously served as chief financial officer of Quantenna Communications and Link-A-Media Devices, both venture capital backed companies, from 2012 to 2013 and from 2010 to 2012 respectively. From 2007 to 2010 he served as chief financial officer and senior vice president of Silicon Storage Technology and from 2000 to 2007 Mr. Boyd served as chief financial officer and senior vice president of ESS Technology, both Nasdaq listed companies. Mr. Boyd earned a B.A. and an M.B.A. in Finance from the University of Wisconsin and a J.D. from Golden Gate University School of Law.
Linda V. Moore

Linda V. Moore,她自2014年3月担任我们公司的副总裁,总法律顾问,秘书长和首席合规官。除了担任 Moore Group 的联合创始人兼董事长,她还是Merix Corp., Phoenix Technologies和Jabil Circuit总法律顾问兼首席合规官。她在知识产权,证券监管与合规,公司治理,劳动关系和诉讼管理领域拥有丰富的经验。她还处理在欧洲,亚洲和拉丁美洲的有关国际税收,劳动力和设施问题的外籍和扩展任务。她在Michigan State University的法学院获得了法学博士学位。


Linda V. Moore was appointed as General Counsel, Secretary and Chief Compliance Officer effective March 2014 and Executive Vice President effective November 6 2017. Ms. Moore co-founded The Moore Group, where she served as principal from 2005 to 2007 during which time she also served as chief operating officer and general counsel of Mobius Photonics, as well as from 2009 to 2014. From 2007 to 2009 Ms. Moore served as executive vice president, general counsel, chief compliance officer and secretary of Merix Corporation. Ms. Moore has served as an Executive Mentor to Astia formerly Women’s Technology Cluster and as a member of the Advisory Board for Remedy Interactive and Opportunity Works. She has also taught at the University of Detroit Mercy and Santa Clara University as an adjunct professor. Ms. Moore earned a J.D. at Michigan State University School of Law.
Linda V. Moore,她自2014年3月担任我们公司的副总裁,总法律顾问,秘书长和首席合规官。除了担任 Moore Group 的联合创始人兼董事长,她还是Merix Corp., Phoenix Technologies和Jabil Circuit总法律顾问兼首席合规官。她在知识产权,证券监管与合规,公司治理,劳动关系和诉讼管理领域拥有丰富的经验。她还处理在欧洲,亚洲和拉丁美洲的有关国际税收,劳动力和设施问题的外籍和扩展任务。她在Michigan State University的法学院获得了法学博士学位。
Linda V. Moore was appointed as General Counsel, Secretary and Chief Compliance Officer effective March 2014 and Executive Vice President effective November 6 2017. Ms. Moore co-founded The Moore Group, where she served as principal from 2005 to 2007 during which time she also served as chief operating officer and general counsel of Mobius Photonics, as well as from 2009 to 2014. From 2007 to 2009 Ms. Moore served as executive vice president, general counsel, chief compliance officer and secretary of Merix Corporation. Ms. Moore has served as an Executive Mentor to Astia formerly Women’s Technology Cluster and as a member of the Advisory Board for Remedy Interactive and Opportunity Works. She has also taught at the University of Detroit Mercy and Santa Clara University as an adjunct professor. Ms. Moore earned a J.D. at Michigan State University School of Law.